AMGN — Amgen Inc. stock price and chart

Share this page

AMGN

$413.08+2.60%

as of close, Oct 7, 2026

☾ AH $413.08 +2.60%

Amgen Inc.Stock · HealthcareDow Jones 4.4%Nasdaq-100 0.8%Nasdaq Composite 0.4%S&P 500 0.3%Russell 1000 0.3%US Stock Market 0.3%Russell 3000 0.3%S&P 500 Equal Weight 0.2%MSCI ACWI 0.2%MSCI World 0.2%

PeersMRNALLYUNHJNJMDTMRK

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDED

20162019202120242026

150.0200.0250.0300.0350.0400.0050.0M$413.08

2026-10-07

Price$413.08

MA20$376.89

MA50$346.54

Vol10.9M

What would $1,000 invested in AMGN be worth today? →

AMGN returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $413.08
YTD price return: +26.20%
YTD total return: +28.79%
Next earnings: Nov 3, 2026
Market cap: 223.3B2016-12 108.8B2026-10 223.3B+105.3% over the window
Enterprise value: 267.5B
Shares outstanding: 540.6M2016-06 748.4M2026-06 540.6M-27.8% over the window
52W low: $288.00
52W high: $447.03
From 52W high: -7.59%
From 52W low: +43.43%
52W range: 79%
Beta: 0.42

Volume

Rel volume: 0.75×
30D volume: 3M
30D $ vol: 1.2B

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.: none
Insider net 3M0 insider-days of buying (no priced lot) and 4 of selling ($4.1M) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$4.1M
Insider net 1Y0 insider-days of buying (no priced lot) and 7 of selling ($25.7M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$25.7M

Form 4 transactions by trade date, as filed; latest on file 2026-08-13.

Fundamentals

Sales (ttm): 38.1B2016-06 22.5B2026-06 38.1B+69.5% over the window
Sales/share: $70.462016-06 $30.032026-06 $70.46+134.6% over the window
EPS (ttm): $16.102016-06 $9.782026-06 $16.10+64.6% over the window
FCF (ttm): 10.2B2016-06 8.9B2026-06 10.2B+14.7% over the window
FCF/share: $18.822016-06 $11.852026-06 $18.82+58.8% over the window
Book value/share: $21.622016-06 $40.272026-06 $21.62-46.3% over the window
Net margin: 22.95%2016-06 33.1%2026-06 23.0%-30.6% over the window
ROE: 74.80%2016-06 24.7%2026-06 74.8%+203.2% over the window
ROA: 9.14%2016-06 9.8%2026-06 9.1%-7.2% over the window
Debt / equity: 4.44×2016-06 0.932026-06 4.44+378.7% over the window
Current ratio: 1.372016-06 3.972026-06 1.37-65.4% over the window

Growth (CAGR, ttm) · 10Y

Sales: +9.11%2025-06-30 → 2026-06-3034.9B → 38.1B (+9.1% total)+12.74%2023-06-30 → 2026-06-3026.6B → 38.1B (+43.3% total)+8.37%2021-06-30 → 2026-06-3025.5B → 38.1B (+49.5% total)+5.42%2016-06-30 → 2026-06-3022.5B → 38.1B (+69.5% total)
Net income: +32.11%2025-06-30 → 2026-06-306.6B → 8.7B (+32.1% total)+3.09%2023-06-30 → 2026-06-308B → 8.7B (+9.6% total)+8.76%2021-06-30 → 2026-06-305.7B → 8.7B (+52.2% total)+1.64%2016-06-30 → 2026-06-307.4B → 8.7B (+17.6% total)
FCF: -4.06%2025-06-30 → 2026-06-3010.6B → 10.2B (-4.1% total)+1.66%2023-06-30 → 2026-06-309.7B → 10.2B (+5.1% total)+2.72%2021-06-30 → 2026-06-308.9B → 10.2B (+14.4% total)+1.38%2016-06-30 → 2026-06-308.9B → 10.2B (+14.7% total)
Shares: +0.42%2025-06-30 → 2026-06-30538.4M → 540.6M (+0.4% total)+0.36%2023-06-30 → 2026-06-30534.9M → 540.6M (+1.1% total)-0.98%2021-06-30 → 2026-06-30567.9M → 540.6M (-4.8% total)-3.20%2016-06-30 → 2026-06-30748.4M → 540.6M (-27.8% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +31.69%2025-06-30 → 2026-06-30$12.23 → $16.10 (+31.7% total)+2.76%2023-06-30 → 2026-06-30$14.84 → $16.10 (+8.5% total)+10.37%2021-06-30 → 2026-06-30$9.83 → $16.10 (+63.8% total)+5.11%2016-06-30 → 2026-06-30$9.78 → $16.10 (+64.6% total)
Sales/share: +8.65%2025-06-30 → 2026-06-30$64.86 → $70.46 (+8.6% total)+12.34%2023-06-30 → 2026-06-30$49.70 → $70.46 (+41.8% total)+9.44%2021-06-30 → 2026-06-30$44.88 → $70.46 (+57.0% total)+8.90%2016-06-30 → 2026-06-30$30.03 → $70.46 (+134.6% total)
FCF/share: -4.46%2025-06-30 → 2026-06-30$19.70 → $18.82 (-4.5% total)+1.30%2023-06-30 → 2026-06-30$18.11 → $18.82 (+3.9% total)+3.74%2021-06-30 → 2026-06-30$15.67 → $18.82 (+20.1% total)+4.73%2016-06-30 → 2026-06-30$11.85 → $18.82 (+58.8% total)
Book value/share: +56.74%2025-06-30 → 2026-06-30$13.80 → $21.62 (+56.7% total)+19.47%2023-06-30 → 2026-06-30$12.68 → $21.62 (+70.5% total)+8.28%2021-06-30 → 2026-06-30$14.52 → $21.62 (+48.9% total)-6.03%2016-06-30 → 2026-06-30$40.27 → $21.62 (-46.3% total)
Dividend/share: -19.88%2025-06-30 → 2026-06-30$9.26 → $7.42 (-19.9% total)-3.78%2023-06-30 → 2026-06-30$8.33 → $7.42 (-10.9% total)+2.00%2021-06-30 → 2026-06-30$6.72 → $7.42 (+10.4% total)+7.56%2016-06-30 → 2026-06-30$3.58 → $7.42 (+107.3% total)
Price: +39.80%2025-10-07 → 2026-10-07$295.54 → $413.08 (+39.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.57%2023-10-06 → 2026-10-07$267.47 → $413.08 (+54.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+14.59%2021-10-07 → 2026-10-07$209.12 → $413.08 (+97.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.48%2016-10-06 → 2026-10-07$166.90 → $413.08 (+147.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +43.68%2025-10-07 → 2026-10-07$287.56 → $413.08 (+43.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+19.08%2023-10-06 → 2026-10-07$244.48 → $413.08 (+69.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+18.21%2021-10-07 → 2026-10-07$178.99 → $413.08 (+130.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.80%2016-10-06 → 2026-10-07$123.86 → $413.08 (+233.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 25.7×2016-12 14.342026-10 25.54+78.1% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 19.5×2016-12 11.642026-10 19.54+67.8% over the window
Fwd P/E: 16.5×
P/S (ttm)Market cap ÷ TTM revenue.: 5.9×2016-12 4.822026-10 5.86+21.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 19.1×2016-12 3.532026-10 19.10+440.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 21.9×2016-12 12.632026-10 21.94+73.7% over the window
EV/EBITDA (fy): 16.6×
EV/Sales (ttm): 7.0×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.56%2016-09 7.9%2026-06 5.2%-34.3% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 2.44%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 2.41%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $10.08
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 540.6M ÷ 538.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.42%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.42%) + dividends paid over that year ($5.3B) ÷ market_cap_at(2025-06-30) ($150.3B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.09%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($223.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 2.0%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $5.3B) ÷ today's market cap ($223.3B). Same caveat as the cash buyback yield.: 2.37%2016-09 4.6%2026-06 2.7%-41.4% over the window

Vs own 10Y history

P/E: 76th
P/OI: 82nd
P/S: 93rd
P/B: 61st
P/FCF: 89th

Bar = where today’s multiple sits in AMGN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-07#

+2.60%

-2.00%

-5.52%

+12.22%

YTD

+26.20%

+39.77%

+97.53%

Recent filings#

Aug 13Insider sale · Khosla Rachna (SVP, Business Development) sold 3,252 shares for $1.3M on 2 days since Aug 11
Aug 6Insider sale · Miller Derek (SVP, Human Resources) sold 3,890 shares for $1.6M at $402.54
Aug 6Insider sale · Grygiel Nancy A. (SVP & CCO) sold 2,970 shares for $1.2M at $402.16
Aug 4Earnings · Earnings release — EPS $6.29 vs $5.60 est. (+12.3%); revenue $10.05B (+10% y/y) 4.6%
Jul 318-K · Material cybersecurity incident

All filings and insider trades →

Financial statements

Open full AMGN financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+3.42%	+2.70%
JNJ	Johnson & Johnson	-6.10%	+1.44%
ABBV	AbbVie Inc.	+5.81%	+1.75%
MRK	Merck & Co. Inc.	-5.02%	+0.60%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-5.33%	-0.09%
TMO	Thermo Fisher Scientific Inc.	+7.87%	+0.83%
GILD	Gilead Sciences Inc.	-2.75%	+1.82%
ABT	Abbott Laboratories	-8.86%	+0.58%

AMGN — Amgen Inc. price, chart and key statistics